Multimorbidity in older adults.

By M. Salive. Epidemiologic Reviews, 2013

1,228 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Epidemiology, Geriatrics and Gerontology

View Paper: https://www.semanticscholar.org/paper/dea140c54ed52e623cf409b5f87cbb42e31e5ff1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. H. Booth

Citations in the corpus

• Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review (2014, neutral): “5% for beneficiaries aged 85 and older.(1) A consequence of multimorbidity is the use of multiple medications.”
• Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model (2018, background): “Multi-morbidity increases the likelihood of hospital admission, length of stay and readmission, raises healthcare costs, reduces quality of life, and increases dependency, polypharmacy and mortality [2, 5].”
• What is polypharmacy? A systematic review of definitions (2017, background): “Background Multimorbidity, commonly defined as the co-existence of two or more chronic health conditions, is common in the older population [1].”